news Histones revealed by study as critical for cell identity 31 October 2019 | By Victoria Rees (Drug Target Review) Researchers have shown that histones are vital in silencing genes and that their position is inherited in new cells, providing insight into how cancer cells can become resistant to therapy.
news Bacteria compete for ‘ownership’ of human tissue 11 December 2018 | By Drug Target Review Research has shown how the same species of bacteria compete for space on human tissue, with researchers saying the mechanism could be used in research...
news Stimulating fibroblasts can trigger hair growth in wound healing 28 November 2018 | By Dr Zara Kassam (Drug Target Review) Stimulating fibroblasts through the sonic hedgehog pathway can trigger hair growth not previously seen in wound healing...
news Mechanism could aid methods to combat immune attacks on the body 27 November 2018 | By Drug Target Review Chemical changes on mRNA were found to control the production of a protein called interferon beta, which could give insights on tackling immune diseases...
news RIP1 kinase as a therapeutic target for pancreatic cancer 12 November 2018 | By Iqra Farooq (Drug Target Review) RIP1 has been shown to suppress the action of macrophages against the immune system and could be a potential therapeutic target for pancreatic cancer...
news Cyclic peptoids show promise as prostate cancer drug 25 October 2018 | By Drug Target Review Scientists in the U.S. have developed molecules, termed cyclic peptoids, that block the action of genes that drive the growth of therapy-resistant prostate cancer, according to a new study.
news Antibodies protect nerve-muscle connections in Lou Gehrig’s disease 26 April 2018 | By Dr Zara Kassam (Drug Target Review) A study identifies a novel treatment strategy that preserved neuromuscular synapses in a mouse model of aggressive ALS...